HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights.
IF 7.6
1区 医学
Q1 CLINICAL NEUROLOGY
Serena Mero,Sara Satolli,Daniele Galatolo,Flavio Dal Canto,Michela Armando,Guja Astrea,Melissa Barghigiani,Giorgia Bruno,Gianmarco Dalla Zanna,Rosa De Micco,Claudia Dosi,Martina Lombardi,Federico Melani,Mariarosa Anna Beatrice Melone,Domenico Montanaro,Rossella Pasquariello,Ivana Ricca,Mariapaola Schifino,Rosanna Trovato,Alessandro Tessitore,Jacopo Troisi,Antonio Varone,Valentina Naef,Filippo M Santorelli
求助PDF
{"title":"HPDL Biallelic Variants in Cerebral Palsy and Childhood-Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights.","authors":"Serena Mero,Sara Satolli,Daniele Galatolo,Flavio Dal Canto,Michela Armando,Guja Astrea,Melissa Barghigiani,Giorgia Bruno,Gianmarco Dalla Zanna,Rosa De Micco,Claudia Dosi,Martina Lombardi,Federico Melani,Mariarosa Anna Beatrice Melone,Domenico Montanaro,Rossella Pasquariello,Ivana Ricca,Mariapaola Schifino,Rosanna Trovato,Alessandro Tessitore,Jacopo Troisi,Antonio Varone,Valentina Naef,Filippo M Santorelli","doi":"10.1002/mds.30296","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nThe human 4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) has been linked to hereditary spastic paraplegia (HSP) with potential roles in neurogenesis and energy metabolism. However, the prevalence of HPDL variants in childhood-onset motor impairments remains unclear.\r\n\r\nOBJECTIVE\r\nThis study set out to characterize new patients with biallelic HPDL variants, and to explore the role of this protein both in vitro and in vivo.\r\n\r\nMETHODS\r\nExome sequencing was performed on 210 patients with HSP, diplegic cerebral palsy (CP), or moderate/severe neurodevelopmental disorders. To understand the role of HPDL, we performed functional studies in patient-derived fibroblasts and crispant (hpdl-F0) zebrafish larvae.\r\n\r\nRESULTS\r\nWe identified 14 patients who exhibited reduced HPDL protein expression in cultured skin fibroblasts. Children with HPDL variants had elevated plasma glial fibrillary acidic protein levels, and serum metabolomics revealed reduced levels of 4-hydroxybenzeneacetic acid, a precursor of 4-hydroxymandelic acid (4HMA) and 4-hydroxybenzoic acid (4HB), with disruptions in metabolic pathways, including the Krebs cycle. The involvement of HPDL in energy metabolism was supported by altered mitochondrial respiration and increased cytosolic reactive oxygen species in human cells. Investigations into hpdl-F0 revealed neurodevelopmental abnormalities and epilepsy-like behavior, likely due to mitochondrial dysfunction, mirroring the phenotypes observed in children. Bypass therapy with 4HMA rescued the disease phenotypes in cells and hpdl-F0 crispant, while 4HB did so only partially in fish.\r\n\r\nCONCLUSIONS\r\nHPDL variants are responsible for CP-like spastic paraparesis in children. Loss of HPDL function disrupts cellular oxidative metabolism, highlighting its role in neurodevelopment and energy homeostasis, both in vitro and in vivo. © 2025 International Parkinson and Movement Disorder Society.","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"14 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Movement Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/mds.30296","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
BACKGROUND
The human 4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) has been linked to hereditary spastic paraplegia (HSP) with potential roles in neurogenesis and energy metabolism. However, the prevalence of HPDL variants in childhood-onset motor impairments remains unclear.
OBJECTIVE
This study set out to characterize new patients with biallelic HPDL variants, and to explore the role of this protein both in vitro and in vivo.
METHODS
Exome sequencing was performed on 210 patients with HSP, diplegic cerebral palsy (CP), or moderate/severe neurodevelopmental disorders. To understand the role of HPDL, we performed functional studies in patient-derived fibroblasts and crispant (hpdl-F0) zebrafish larvae.
RESULTS
We identified 14 patients who exhibited reduced HPDL protein expression in cultured skin fibroblasts. Children with HPDL variants had elevated plasma glial fibrillary acidic protein levels, and serum metabolomics revealed reduced levels of 4-hydroxybenzeneacetic acid, a precursor of 4-hydroxymandelic acid (4HMA) and 4-hydroxybenzoic acid (4HB), with disruptions in metabolic pathways, including the Krebs cycle. The involvement of HPDL in energy metabolism was supported by altered mitochondrial respiration and increased cytosolic reactive oxygen species in human cells. Investigations into hpdl-F0 revealed neurodevelopmental abnormalities and epilepsy-like behavior, likely due to mitochondrial dysfunction, mirroring the phenotypes observed in children. Bypass therapy with 4HMA rescued the disease phenotypes in cells and hpdl-F0 crispant, while 4HB did so only partially in fish.
CONCLUSIONS
HPDL variants are responsible for CP-like spastic paraparesis in children. Loss of HPDL function disrupts cellular oxidative metabolism, highlighting its role in neurodevelopment and energy homeostasis, both in vitro and in vivo. © 2025 International Parkinson and Movement Disorder Society.
脑瘫和儿童期遗传性痉挛性截瘫的HPDL双等位基因变异:人类和斑马鱼的观察。
人类4-羟基苯基丙酮酸双加氧酶样蛋白(HPDL)与遗传性痉挛性截瘫(HSP)有关,在神经发生和能量代谢中具有潜在作用。然而,HPDL变异在儿童期发病的运动障碍中的患病率仍不清楚。目的:本研究旨在描述新的双等位HPDL变异患者的特征,并探讨该蛋白在体外和体内的作用。方法对210例HSP、双瘫性脑瘫(CP)或中重度神经发育障碍患者进行基因组测序。为了了解HPDL的作用,我们对患者来源的成纤维细胞和脆化(HPDL - f0)斑马鱼幼虫进行了功能研究。结果我们发现14例患者在培养的皮肤成纤维细胞中HPDL蛋白表达降低。患有HPDL变异的儿童血浆胶质原纤维酸性蛋白水平升高,血清代谢组学显示4-羟基苯乙酸(4 -羟基杏仁酸(4HMA)和4-羟基苯甲酸(4HB)的前体)水平降低,代谢途径中断,包括克雷伯循环。人类细胞中线粒体呼吸改变和胞质活性氧增加支持HPDL参与能量代谢。对hpdl-F0的调查揭示了神经发育异常和癫痫样行为,可能是由于线粒体功能障碍,反映了在儿童中观察到的表型。4HMA旁路治疗在细胞和hpdl-F0中挽救了疾病表型,而4HB在鱼类中仅部分起作用。结论shpdl变异与儿童cp样痉挛性截瘫有关。HPDL功能的丧失会破坏细胞氧化代谢,突出其在体外和体内神经发育和能量稳态中的作用。©2025国际帕金森和运动障碍学会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
来源期刊
期刊介绍:
Movement Disorders publishes a variety of content types including Reviews, Viewpoints, Full Length Articles, Historical Reports, Brief Reports, and Letters. The journal considers original manuscripts on topics related to the diagnosis, therapeutics, pharmacology, biochemistry, physiology, etiology, genetics, and epidemiology of movement disorders. Appropriate topics include Parkinsonism, Chorea, Tremors, Dystonia, Myoclonus, Tics, Tardive Dyskinesia, Spasticity, and Ataxia.